AMLX
Price:
$6.22
Market Cap:
$423.47M
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2022-01-07
Stock Exchange
NASDAQ
Ticker
AMLX
According to Amylyx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 351.61M. This represents a change of -29.79% compared to the average of 500.83M of the last 4 quarters.
The mean historical Enterprise Value of Amylyx Pharmaceuticals, Inc. over the last ten years is 1.25B. The current 351.61M Enterprise Value has changed 2.71% with respect to the historical average. Over the past ten years (40 quarters), AMLX's Enterprise Value was at its highest in in the December 2022 quarter at 2.36B. The Enterprise Value was at its lowest in in the June 2021 quarter at 0.
Average
1.25B
Median
1.01B
Minimum
823.73M
Maximum
2.40B
Discovering the peaks and valleys of Amylyx Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 141.24%
Maximum Annual Enterprise Value = 2.40B
Minimum Annual Increase = -65.70%
Minimum Annual Enterprise Value = 823.73M
Year | Enterprise Value | Change |
---|---|---|
2023 | 823.73M | -65.70% |
2022 | 2.40B | 141.24% |
2021 | 995.41M | -1.34% |
2020 | 1.01B | -2.26% |
The current Enterprise Value of Amylyx Pharmaceuticals, Inc. (AMLX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.41B
5-year avg
1.25B
10-year avg
1.25B
Amylyx Pharmaceuticals, Inc.’s Enterprise Value is less than Terns Pharmaceuticals, Inc. (520.07M), greater than Acumen Pharmaceuticals, Inc. (154.32M), greater than Inozyme Pharma, Inc. (287.58M), greater than X4 Pharmaceuticals, Inc. (28.55M), less than Day One Biopharmaceuticals, Inc. (1.14B), less than Mereo BioPharma Group plc (549.16M), greater than PDS Biotechnology Corporation (85.57M), greater than HOOKIPA Pharma Inc. (-25962570.00),
Company | Enterprise Value | Market cap |
---|---|---|
520.07M | $611.32M | |
154.32M | $194.06M | |
287.58M | $265.37M | |
28.55M | $97.54M | |
1.14B | $1.56B | |
549.16M | $630.43M | |
85.57M | $118.93M | |
-25962570.00 | $46.29M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amylyx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Amylyx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Amylyx Pharmaceuticals, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Amylyx Pharmaceuticals, Inc. (AMLX)?
What is the 3-year average Enterprise Value for Amylyx Pharmaceuticals, Inc. (AMLX)?
What is the 5-year average Enterprise Value for Amylyx Pharmaceuticals, Inc. (AMLX)?
How does the current Enterprise Value for Amylyx Pharmaceuticals, Inc. (AMLX) compare to its historical average?